Post by VIB

📩 More than 200 biotech companies, investors, and life sciences organizations are sending a clear message to Europe’s leaders: Europe cannot afford to let its life sciences innovation slip away. That is why VIB supports the open letter from the European Life Sciences Coalition (ELSC), calling for urgent action to strengthen Europe’s life sciences ecosystem. The message is clear: Europe must improve access to growth capital, make regulation more efficient, and create the right conditions for biotech companies to scale in Europe. 📈 “Europe has the science, entrepreneurship, and biotech ecosystem to lead globally in life sciences. But to turn breakthroughs into companies, treatments, and patient impact here in Europe, we need faster action on growth capital, smarter regulation, and a stronger innovation environment. The support of more than 200 companies and investors shows how broad and urgent this call is.” - Jerome Van Biervliet, Managing Director of VIB. This is about patients, jobs, competitiveness, and Europe’s strategic position. ➡️ Read more via the link in the comments. Invest Europe Novo Holdings Forbion Sofinnova Partners HealthCap Omega Funds Cooley LLP Covington & Burling LLP Van Lanschot Kempen Andera Partners BioInnovation Institute (BII) #LifeSciences #Biotech #Innovation #Europe